Copyright Reports & Markets. All rights reserved.

Global Weight Reduction Medicine Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Weight Reduction Medicine Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Weight Reduction Medicine Market Size Growth Rate by Product
      • 1.4.2 Liauid
      • 1.4.3 Tablets
    • 1.5 Market by End User
      • 1.5.1 Global Weight Reduction Medicine Market Size Growth Rate by End User
      • 1.5.2 Weight-reducing Aid
      • 1.5.3 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Weight Reduction Medicine Market Size
      • 2.1.1 Global Weight Reduction Medicine Revenue 2014-2025
      • 2.1.2 Global Weight Reduction Medicine Sales 2014-2025
    • 2.2 Weight Reduction Medicine Growth Rate by Regions
      • 2.2.1 Global Weight Reduction Medicine Sales by Regions
      • 2.2.2 Global Weight Reduction Medicine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Weight Reduction Medicine Sales by Manufacturers
      • 3.1.1 Weight Reduction Medicine Sales by Manufacturers
      • 3.1.2 Weight Reduction Medicine Sales Market Share by Manufacturers
      • 3.1.3 Global Weight Reduction Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Weight Reduction Medicine Revenue by Manufacturers
      • 3.2.1 Weight Reduction Medicine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Weight Reduction Medicine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Weight Reduction Medicine Price by Manufacturers
    • 3.4 Weight Reduction Medicine Manufacturing Base Distribution, Product Types
      • 3.4.1 Weight Reduction Medicine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Weight Reduction Medicine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Weight Reduction Medicine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Weight Reduction Medicine Sales by Product
    • 4.2 Global Weight Reduction Medicine Revenue by Product
    • 4.3 Weight Reduction Medicine Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Weight Reduction Medicine Breakdown Data by End User

    6 North America

    • 6.1 North America Weight Reduction Medicine by Countries
      • 6.1.1 North America Weight Reduction Medicine Sales by Countries
      • 6.1.2 North America Weight Reduction Medicine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Weight Reduction Medicine by Product
    • 6.3 North America Weight Reduction Medicine by End User

    7 Europe

    • 7.1 Europe Weight Reduction Medicine by Countries
      • 7.1.1 Europe Weight Reduction Medicine Sales by Countries
      • 7.1.2 Europe Weight Reduction Medicine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Weight Reduction Medicine by Product
    • 7.3 Europe Weight Reduction Medicine by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Weight Reduction Medicine by Countries
      • 8.1.1 Asia Pacific Weight Reduction Medicine Sales by Countries
      • 8.1.2 Asia Pacific Weight Reduction Medicine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Weight Reduction Medicine by Product
    • 8.3 Asia Pacific Weight Reduction Medicine by End User

    9 Central & South America

    • 9.1 Central & South America Weight Reduction Medicine by Countries
      • 9.1.1 Central & South America Weight Reduction Medicine Sales by Countries
      • 9.1.2 Central & South America Weight Reduction Medicine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Weight Reduction Medicine by Product
    • 9.3 Central & South America Weight Reduction Medicine by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Weight Reduction Medicine by Countries
      • 10.1.1 Middle East and Africa Weight Reduction Medicine Sales by Countries
      • 10.1.2 Middle East and Africa Weight Reduction Medicine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Weight Reduction Medicine by Product
    • 10.3 Middle East and Africa Weight Reduction Medicine by End User

    11 Company Profiles

    • 11.1 Roche
      • 11.1.1 Roche Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Roche Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Roche Weight Reduction Medicine Products Offered
      • 11.1.5 Roche Recent Development
    • 11.2 GSK group
      • 11.2.1 GSK group Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GSK group Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GSK group Weight Reduction Medicine Products Offered
      • 11.2.5 GSK group Recent Development
    • 11.3 Teva
      • 11.3.1 Teva Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Teva Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Teva Weight Reduction Medicine Products Offered
      • 11.3.5 Teva Recent Development
    • 11.4 Sandoz(Novartis)
      • 11.4.1 Sandoz(Novartis) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sandoz(Novartis) Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sandoz(Novartis) Weight Reduction Medicine Products Offered
      • 11.4.5 Sandoz(Novartis) Recent Development
    • 11.5 STADA-VN J.V.Co., Ltd
      • 11.5.1 STADA-VN J.V.Co., Ltd Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 STADA-VN J.V.Co., Ltd Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 STADA-VN J.V.Co., Ltd Weight Reduction Medicine Products Offered
      • 11.5.5 STADA-VN J.V.Co., Ltd Recent Development
    • 11.6 Hexal AG
      • 11.6.1 Hexal AG Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Hexal AG Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Hexal AG Weight Reduction Medicine Products Offered
      • 11.6.5 Hexal AG Recent Development
    • 11.7 National Company For Pharmaceutical Industry
      • 11.7.1 National Company For Pharmaceutical Industry Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 National Company For Pharmaceutical Industry Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 National Company For Pharmaceutical Industry Weight Reduction Medicine Products Offered
      • 11.7.5 National Company For Pharmaceutical Industry Recent Development
    • 11.8 Lunan Pharmaceutical Group Corporation
      • 11.8.1 Lunan Pharmaceutical Group Corporation Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Lunan Pharmaceutical Group Corporation Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Lunan Pharmaceutical Group Corporation Weight Reduction Medicine Products Offered
      • 11.8.5 Lunan Pharmaceutical Group Corporation Recent Development
    • 11.9 Zein Pharmaceutical
      • 11.9.1 Zein Pharmaceutical Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Zein Pharmaceutical Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Zein Pharmaceutical Weight Reduction Medicine Products Offered
      • 11.9.5 Zein Pharmaceutical Recent Development
    • 11.10 Hisun
      • 11.10.1 Hisun Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Hisun Weight Reduction Medicine Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Hisun Weight Reduction Medicine Products Offered
      • 11.10.5 Hisun Recent Development
    • 11.11 Taj Pharmaceuticals Ltd
    • 11.12 Kabir Life Sciences & Research
    • 11.13 Dm Pharma
    • 11.14 China Zhongshan Pharm

    12 Future Forecast

    • 12.1 Weight Reduction Medicine Market Forecast by Regions
      • 12.1.1 Global Weight Reduction Medicine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Weight Reduction Medicine Revenue Forecast by Regions 2019-2025
    • 12.2 Weight Reduction Medicine Market Forecast by Product
      • 12.2.1 Global Weight Reduction Medicine Sales Forecast by Product 2019-2025
      • 12.2.2 Global Weight Reduction Medicine Revenue Forecast by Product 2019-2025
    • 12.3 Weight Reduction Medicine Market Forecast by End User
    • 12.4 North America Weight Reduction Medicine Forecast
    • 12.5 Europe Weight Reduction Medicine Forecast
    • 12.6 Asia Pacific Weight Reduction Medicine Forecast
    • 12.7 Central & South America Weight Reduction Medicine Forecast
    • 12.8 Middle East and Africa Weight Reduction Medicine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Weight Reduction Medicine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Weight Reduction Medicine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Weight Reduction Medicine market based on company, product type, end user and key regions.

      This report studies the global market size of Weight Reduction Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Weight Reduction Medicine in these regions.
      This research report categorizes the global Weight Reduction Medicine market by top players/brands, region, type and end user. This report also studies the global Weight Reduction Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Roche
      GSK group
      Teva
      Sandoz(Novartis)
      STADA-VN J.V.Co., Ltd
      Hexal AG
      National Company For Pharmaceutical Industry
      Lunan Pharmaceutical Group Corporation
      Zein Pharmaceutical
      Hisun
      Taj Pharmaceuticals Ltd
      Kabir Life Sciences & Research
      Dm Pharma
      China Zhongshan Pharm

      Market size by Product
      Liauid
      Tablets
      Market size by End User
      Weight-reducing Aid
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Weight Reduction Medicine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Weight Reduction Medicine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Weight Reduction Medicine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Weight Reduction Medicine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Weight Reduction Medicine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Weight Reduction Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now